Researchers have developed a method to analyze blood samples with just 5 % cancer DNA, compared to the 15–20 % required today—opening the door to improved cancer care and tumor monitoring.

Study shows that some of the genetic changes in cats tumors resemble closely to those found in human cancers. These parallels open new perspectives for developing targeted cancer therapies, particularly for breast cancer.

A recent study has revealed that valvular heart disease is common in cancer patients and that interventions to treat this disease significantly improved survival.

Scientists have revealed that a drug that is widely used to treat asthma and allergies may also help fight aggressive cancers. The findings suggest that it is a new way to improve treatment for tough tumors, such as triple-negative breast cancer, where immunotherapy often fails.

While reviewing lung cancer CT scans, doctors sometimes spot abnormalities unrelated to the lungs. New research has now shown that some of those abnormalities could be signs of other undiagnosed cancers.

The ‘Cardiocare’ project is focusing on a vulnerable group of patients – women over 65 with breast cancer at risk of cardiotoxicity from cancer treatment. The project is currently celebrating a series of major achievements that bring its ambitious vision closer to reality: smarter, more personalized and more patient-centered care for this patient group.

Gene editing could help solve one of the biggest problems in treating aggressive blood cancers: how to attack cancer cells without destroying healthy donor cells. A new multicentre trial shows that CRISPR-modified stem cell transplants may make CD33-targeted therapies safer and more effective after transplantation.

Scientists have revealed that a highly sensitive blood test can now detect traces of pancreatic cancer that are missed by standard testing. The simple test can help identify patients whose disease is more likely to return even when scans appear reassuring.

Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, supercharges a critical class of immune cells that activate and prepare the body’s key cancer-fighters, according to new UCLA research.

Researchers have developed a high-throughput method to identify gold nanoparticles capable of delivering therapies directly to the mitochondria, the energy centres inside cancer cells.